Schiff income up
This article was originally published in The Tan Sheet
The Salt Lake City company attributes its fiscal 2010 first-quarter profitability to strong branded sales offsetting a decline in private-label volume. Schiff Nutrition International reported a 35.1 percent leap in net income to $4.4 million in the three months ended Aug. 31, along with net sales growth of 1.6 percent to $48.6 million. Net income per share was 15 cents in the quarter, compared to 11 cents in the year-ago period, Schiff said Sept. 17. The firm pared costs in the quarter, reducing selling and marketing expenses to $6.6 million from $8.1 million
You may also be interested in...
With the meetings available on television, access can be assured for just about everyone, and the US FDA can avoid another gut punch to its credibility.
Japan approves a batch of new products and indications, including Daiichi Sankyo's Enhertu in a high-need indication after a rapid review and Takeda's Zejula, which will be made available to selected patients before its reimbursement listing.
Public Company Edition: Outside the US, Zai Lab raised more in its recent Hong Kong initial public offering – $766.4m – than PMV, Prelude, Taysha, Graybug and Greenwich combined. Also, Gilead priced debt to fund its $21bn Immunomedics buy and ADC Therapeutics raised $204m.